Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

589 ARTÍCULOS , VIENDO DEL 466 AL 480

Committee on High-quality Alzheimer's Disease Studies (CHADS) consensus report

Jicha GA, Abner EL, Arnold SE, Carrillo MC, Dodge HH, Edland SD, Fargo KN, Feldman HH, Goldstein LB, Hendrix J, Peters R, Robillard JM, Schneider LS, Titiner JR, Weber CJ; Clinical Trial Advancement & Methodology Professional Interest Area of the International Society to Advance Alzheimer's Research and Treatment (ISTAART).

Alzheimers Dement. 2022 Jun;18(6):1109-1118. doi: 10.1002/alz.12461. Epub 2021 Sep 29.

Network activity changes in the pathophysiology of Alzheimer's disease: the role of aging and early entorhinal cortex dysfunction

Setti SE, Reed MN.

Metab Brain Dis. 2022 Feb;37(2):289-298. doi: 10.1007/s11011-021-00848-8. Epub 2021 Sep 30.

Accelerated Approval of Aducanumab: Where Do We Stand Now?

Barenholtz Levy H.

Ann Pharmacother. 2022 Jun;56(6):736-739. doi: 10.1177/10600280211050405. Epub 2021 Oct 1.

The efficacy and safety of zolpidem and zopiclone to treat insomnia in Alzheimer's disease: a randomized, triple-blind, placebo-controlled trial

Louzada LL, Machado FV, Quintas JL, Ribeiro GA, Silva MV, Mendonça-Silva DL, Gonçalves BSB, Nóbrega OT, Camargos EF.

Neuropsychopharmacology. 2022 Jan;47(2):570-579. doi: 10.1038/s41386-021-01191-3. Epub 2021 Oct 11.

Of education and public policy: Aducanumab

Lundebjerg NE, Hollmann PA, Supiano MA.

J Am Geriatr Soc. 2022 Jan;70(1):81-84. doi: 10.1111/jgs.17523. Epub 2021 Nov 3.

Secretases in Alzheimer's disease: Novel insights into proteolysis of APP and TREM2

Lichtenthaler SF, Tschirner SK, Steiner H.

Curr Opin Neurobiol. 2022 Feb;72:101-110. doi: 10.1016/j.conb.2021.09.003. Epub 2021 Oct 22.

Population pharmacokinetics and standard uptake value ratio of aducanumab, an amyloid plaque-removing agent, in patients with Alzheimer's disease

Kandadi Muralidharan K, Tong X, Kowalski KG, Rajagovindan R, Lin L, Budd Haberlain S, Nestorov I.

CPT Pharmacometrics Syst Pharmacol. 2022 Jan;11(1):7-19. doi: 10.1002/psp4.12728. Epub 2021 Oct 26.

Oxidative stress-A direct bridge to central nervous system homeostatic dysfunction and Alzheimer's disease

Anwar MM.

Cell Biochem Funct. 2022 Jan;40(1):17-27. doi: 10.1002/cbf.3673. Epub 2021 Oct 30.

Chinese Herbal Medicine Adjusting Brain Microenvironment via Mediating Central Nervous System Lymphatic Drainage in Alzheimer's Disease

Zhou XB, Zhang YX, Zhou CX, Ma JJ.

Chin J Integr Med. 2022 Feb;28(2):176-184. doi: 10.1007/s11655-021-3342-5. Epub 2021 Nov 3.

Therapeutic potential of quinazoline derivatives for Alzheimer's disease: A comprehensive review

Haghighijoo Z, Zamani L, Moosavi F, Emami S.

Eur J Med Chem. 2022 Jan 5;227:113949. doi: 10.1016/j.ejmech.2021.113949. Epub 2021 Oct 27.

Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer's Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside

Walia V, Kaushik D, Mittal V, Kumar K, Verma R, Parashar J, Akter R, Rahman MH, Bhatia S, Al-Harrasi A, Karthika C, Bhattacharya T, Chopra H, Ashraf GM.

Mol Neurobiol. 2022 Jan;59(1):657-680. doi: 10.1007/s12035-021-02617-1. Epub 2021 Nov 9.

An alarm on vitamin D therapy for Alzheimer's disease patients: a case with Alzheimer's disease whose symptoms were exacerbated under chronic use of eldecalcitol

Nakajima-Ohyama KC, Tansho K, Tanimukai H.

Psychogeriatrics. 2022 Jan;22(1):145-148. doi: 10.1111/psyg.12786. Epub 2021 Nov 10.

Formaldehyde toxicity in age-related neurological dementia

Kou Y, Zhao H, Cui D, Han H, Tong Z.

Ageing Res Rev. 2022 Jan;73:101512. doi: 10.1016/j.arr.2021.101512. Epub 2021 Nov 17.

Harnessing cerebral organoids for Alzheimer's disease research

Bubnys A, Tsai LH.

Curr Opin Neurobiol. 2022 Feb;72:120-130. doi: 10.1016/j.conb.2021.10.003. Epub 2021 Nov 21.

Therapeutic potential of neurotrophic factors in Alzheimer's Disease

Nasrolahi A, Javaherforooshzadeh F, Jafarzadeh-Gharehziaaddin M, Mahmoudi J, Asl KD, Shabani Z.

Mol Biol Rep. 2022 Mar;49(3):2345-2357. doi: 10.1007/s11033-021-06968-9. Epub 2021 Nov 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias